254 related articles for article (PubMed ID: 27925342)
1. Vascular endothelial growth factor G+405C polymorphism may contribute to the risk of developing papillary thyroid carcinoma.
Bingül İ; Vural P; Doğru-Abbasoğlu S; Çil E; Uysal M
J Clin Lab Anal; 2017 Nov; 31(6):. PubMed ID: 27925342
[TBL] [Abstract][Full Text] [Related]
2. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population.
Maltese P; Canestrari E; Ruzzo A; Graziano F; Falcone A; Loupakis F; Tonini G; Santini D; Magnani M
Int J Colorectal Dis; 2009 Feb; 24(2):165-70. PubMed ID: 18830612
[TBL] [Abstract][Full Text] [Related]
3. Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.
Yuan Q; Bu Q; Li G; Zhang J; Cui T; Zhu R; Mu D
Clin Endocrinol (Oxf); 2016 Apr; 84(4):564-70. PubMed ID: 26052935
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor polymorphisms increase the risk of developing Graves' disease.
Vural P; Baki M; Doğru-Abbasoğlu S; Özderya A; Karadağ B; Uysal M
Int Immunopharmacol; 2012 Oct; 14(2):133-7. PubMed ID: 22771446
[TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.
Song CM; Kwon TK; Park BL; Ji YB; Tae K
Environ Mol Mutagen; 2015 Jan; 56(1):70-6. PubMed ID: 25196645
[TBL] [Abstract][Full Text] [Related]
6. Role of MDM2 309T>G (rs2279744) and I/D (rs3730485) polymorphisms and haplotypes in risk of papillary thyroid carcinoma, tumor stage, tumor size, and early onset of tumor: A case control study.
Maruei-Milan R; Heidari Z; Salimi S
J Cell Physiol; 2019 Aug; 234(8):12934-12940. PubMed ID: 30548972
[TBL] [Abstract][Full Text] [Related]
7. Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.
Lin L; Cao K; Chen W; Pan X; Zhao H
PLoS One; 2013; 8(10):e75123. PubMed ID: 24098368
[TBL] [Abstract][Full Text] [Related]
8. Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.
Yuan K; Huo M; Sun Y; Wu H; Chen H; Wang Y; Fu R
Tumour Biol; 2016 Jan; 37(1):979-87. PubMed ID: 26264616
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.
Çil E; Kumral A; Kanmaz-Özer M; Vural P; Doğru-Abbasoğlu S; Altuntaş Y; Uysal M
Mol Biol Rep; 2014 May; 41(5):3091-7. PubMed ID: 24464184
[TBL] [Abstract][Full Text] [Related]
10. Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma.
Ge M; Shi M; An C; Yang W; Nie X; Zhang J; Lv Z; Li J; Zhou L; Du Z; Yang M
Sci Rep; 2016 May; 6():26037. PubMed ID: 27185198
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
[TBL] [Abstract][Full Text] [Related]
12. Interaction Between XRCC1 Gene Polymorphisms and Obesity on Susceptibility to Papillary Thyroid Cancer in Chinese Han Population.
Zhu J; Qi P; Li Z
Cell Physiol Biochem; 2018; 49(2):638-644. PubMed ID: 30165355
[TBL] [Abstract][Full Text] [Related]
13. Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
Lonjou C; Damiola F; Moissonnier M; Durand G; Malakhova I; Masyakin V; Le Calvez-Kelm F; Cardis E; Byrnes G; Kesminiene A; Lesueur F
BMC Cancer; 2017 May; 17(1):328. PubMed ID: 28499365
[TBL] [Abstract][Full Text] [Related]
14. Association of FOXE1 polyalanine repeat region with papillary thyroid cancer.
Bullock M; Duncan EL; O'Neill C; Tacon L; Sywak M; Sidhu S; Delbridge L; Learoyd D; Robinson BG; Ludgate M; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1814-9. PubMed ID: 22736773
[TBL] [Abstract][Full Text] [Related]
15. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
Dong G; Zhang R; Xu J; Guo Y
Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
[TBL] [Abstract][Full Text] [Related]
16. Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.
Chen P; Sun R; Pu Y; Bai P; Yuan F; Liang Y; Zhou B; Wang Y; Sun Y; Zhu J; Zhang L; Gao L
Medicine (Baltimore); 2015 Sep; 94(38):e1536. PubMed ID: 26402809
[TBL] [Abstract][Full Text] [Related]
17. Association of +405C>G and +936C>T polymorphisms of the vascular endothelial growth factor gene with sporadic breast cancer in North Indians.
Kapahi R; Manjari M; Sudan M; Uppal MS; Singh NR; Sambyal V; Guleria K
Asian Pac J Cancer Prev; 2014; 15(1):257-63. PubMed ID: 24528036
[TBL] [Abstract][Full Text] [Related]
18. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.
Lesueur F; Corbex M; McKay JD; Lima J; Soares P; Griseri P; Burgess J; Ceccherini I; Landolfi S; Papotti M; Amorim A; Goldgar DE; Romeo G
J Med Genet; 2002 Apr; 39(4):260-5. PubMed ID: 11950855
[TBL] [Abstract][Full Text] [Related]
19. Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population.
Eun YG; Shin IH; Kim MJ; Chung JH; Song JY; Kwon KH
Surgery; 2012 Feb; 151(2):323-9. PubMed ID: 21982075
[TBL] [Abstract][Full Text] [Related]
20. Association between IL-27 gene polymorphisms and risk of papillary thyroid carcinoma.
Nie X; Yuan F; Chen P; Pu Y; Zhu J; Wang Y; Xiao X; Che G; Gao L; Zhang L
Biomark Med; 2017 Feb; 11(2):141-149. PubMed ID: 27929666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
